S233-1735 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide

S233-1735 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide
S233-1735 Screening compound: N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S233-1735
N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S233-1735

Molecular Formula

C21H32N4O2 (C21 H32 N4 O2)

Compound Name

N-{[1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide

IUPAC name

N-{[(4aS7aR)-1-(cyclohexylmethyl)-2-oxo-octahydro-1H-cyclopenta[b]pyridin-4a-yl]methyl}-2-(1H-pyrazol-1-yl)acetamide

SMILES

O=C(Cn1nccc1)NC[C@](CCC1)(CC2)[C@@H]1N(CC1CCCCC1)C2=O

InChI

InChI=1S/C21H32N4O2/c26-19(15-24-13-5-12-23-24)22-16-21-10-4-8-18(21)25(20(27)9-11-21)14-17-6-2-1-3-7-17/h5,12-13,17-18H,1-4,6-11,14-16H2,(H,22,26)/t18-,21+/m1/s1

InChI Key

YFZDHSZIWMYIFM-NQIIRXRSSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.673

Distribution Coefficient, logD

2.673

Water Solubility, LogSw

-2.65

Polar Surface Area

55.717

Acid Dissociation Constant (pKa)

14.49

Base Dissociation Constant (pKb)

6.83

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

76.20

S233-1735 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S233-1735 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S233-1735?
Check Price and Availability of S233-1735, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S233-1735 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S233-1735
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S233-1735
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S233-1735 available by request